The protective effects of shikonin on hepatic ischemia/reperfusion injury are mediated by the activation of the PI3K/Akt pathway

[1]  S. Ferrari,et al.  Author contributions , 2021 .

[2]  H. Xi,et al.  Shikonin induces mitochondria-mediated apoptosis and enhances chemotherapeutic sensitivity of gastric cancer through reactive oxygen species , 2016, Scientific Reports.

[3]  J. Tao,et al.  Tea polyphenols protect against ischemia/reperfusion-induced liver injury in mice through anti-oxidative and anti-apoptotic properties. , 2016, Experimental and therapeutic medicine.

[4]  W. Yao,et al.  Hyperglycemia Aggravates Hepatic Ischemia Reperfusion Injury by Inducing Chronic Oxidative Stress and Inflammation , 2016, Oxidative medicine and cellular longevity.

[5]  Weihua Zhao,et al.  Gypenoside Protects against Myocardial Ischemia-Reperfusion Injury by Inhibiting Cardiomyocytes Apoptosis via Inhibition of CHOP Pathway and Activation of PI3K/Akt Pathway In Vivo and In Vitro , 2016, Cellular Physiology and Biochemistry.

[6]  Qi Wang,et al.  Caveolin-1 protects against hepatic ischemia/reperfusion injury through ameliorating peroxynitrite-mediated cell death. , 2016, Free radical biology & medicine.

[7]  Jiao Feng,et al.  Shikonin Attenuates Concanavalin A-Induced Acute Liver Injury in Mice via Inhibition of the JNK Pathway , 2016, Mediators of inflammation.

[8]  Fan Wang,et al.  15d-PGJ2 alleviates ConA-induced acute liver injury in mice by up-regulating HO-1 and reducing hepatic cell autophagy. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[9]  Fan Wang,et al.  Pretreatment with Fucoidan from Fucus vesiculosus Protected against ConA-Induced Acute Liver Injury by Inhibiting Both Intrinsic and Extrinsic Apoptosis , 2016, PloS one.

[10]  Wei Chen,et al.  Protective effects of fenofibrate against acute lung injury induced by intestinal ischemia/reperfusion in mice , 2016, Scientific Reports.

[11]  Fan Wang,et al.  Epigallocatechin-3-gallate attenuates apoptosis and autophagy in concanavalin A-induced hepatitis by inhibiting BNIP3 , 2016, Drug design, development and therapy.

[12]  Chen Yan,et al.  Higenamine protects ischemia/reperfusion induced cardiac injury and myocyte apoptosis through activation of β2-AR/PI3K/AKT signaling pathway. , 2016, Pharmacological research.

[13]  Xiaoming Fan,et al.  Ghrelin reduces liver impairment in a model of concanavalin A-induced acute hepatitis in mice , 2015, Drug design, development and therapy.

[14]  Fan Wang,et al.  Astaxanthin Pretreatment Attenuates Hepatic Ischemia Reperfusion-Induced Apoptosis and Autophagy via the ROS/MAPK Pathway in Mice , 2015, Marine drugs.

[15]  Fan Wang,et al.  Protective Effects of Astaxanthin on ConA-Induced Autoimmune Hepatitis by the JNK/p-JNK Pathway-Mediated Inhibition of Autophagy and Apoptosis , 2015, PloS one.

[16]  Fan Wang,et al.  Protective Effects of N-Acetylcysteine in Concanavalin A-Induced Hepatitis in Mice , 2015, Mediators of inflammation.

[17]  Haw‐Wen Chen,et al.  Shikonin inhibits oxidized LDL-induced monocyte adhesion by suppressing NFκB activation via up-regulation of PI3K/Akt/Nrf2-dependent antioxidation in EA.hy926 endothelial cells. , 2015, Biochemical pharmacology.

[18]  Y. Li,et al.  Shikonin protects chondrocytes from interleukin-1beta-induced apoptosis by regulating PI3K/Akt signaling pathway. , 2015, International journal of clinical and experimental pathology.

[19]  Ling Zhang,et al.  Helium preconditioning protects mouse liver against ischemia and reperfusion injury through the PI3K/Akt pathway. , 2014, Journal of hepatology.

[20]  Feng Wang,et al.  15d-Prostaglandin J2 Protects Cortical Neurons Against Oxygen–Glucose Deprivation/Reoxygenation Injury: Involvement of Inhibiting Autophagy Through Upregulation of Bcl-2 , 2014, Cellular and Molecular Neurobiology.

[21]  I. Dontas,et al.  Rodent models of hepatic ischemia-reperfusion injury: time and percentage-related pathophysiological mechanisms. , 2014, The Journal of surgical research.

[22]  Jinyong Peng,et al.  Dioscin Attenuates Hepatic Ischemia-Reperfusion Injury in Rats Through Inhibition of Oxidative-Nitrative Stress, Inflammation and Apoptosis , 2014, Transplantation.

[23]  Miao Shen,et al.  Hydrogen sulfide, a potential novel drug, attenuates concanavalin A-induced hepatitis , 2014, Drug design, development and therapy.

[24]  Fan Wang,et al.  Hydrogen Sulfide Ameliorates Ischemia/Reperfusion-Induced Hepatitis by Inhibiting Apoptosis and Autophagy Pathways , 2014, Mediators of inflammation.

[25]  J. Kalbfleisch,et al.  The TLR9 Ligand, CpG‐ODN, Induces Protection against Cerebral Ischemia/Reperfusion Injury via Activation of PI3K/Akt Signaling , 2014, Journal of the American Heart Association.

[26]  P. Panda,et al.  Autophagy and apoptosis: where do they meet? , 2014, Apoptosis.

[27]  Fan Wang,et al.  Ethyl Pyruvate Ameliorates Hepatic Ischemia-Reperfusion Injury by Inhibiting Intrinsic Pathway of Apoptosis and Autophagy , 2013, Mediators of inflammation.

[28]  Sheng Wang,et al.  Protective Effect of Shikonin in Experimental Ischemic Stroke: Attenuated TLR4, p-p38MAPK, NF-κB, TNF-α and MMP-9 Expression, Up-Regulated Claudin-5 Expression, Ameliorated BBB Permeability , 2013, Neurochemical Research.

[29]  Guanghui Wang,et al.  Cerebral ischemia-reperfusion-induced autophagy protects against neuronal injury by mitochondrial clearance , 2013, Autophagy.

[30]  G. Kaushal.  Autophagy protects proximal tubular cells from injury and apoptosis. , 2012, Kidney international.

[31]  L. Margaritis,et al.  Detrimental effects of proteasome inhibition activity in Drosophila melanogaster: implication of ER stress, autophagy, and apoptosis , 2012, Cell Biology and Toxicology.

[32]  Defeng Xu,et al.  Shikonin and its derivatives: a patent review , 2012, Expert opinion on therapeutic patents.

[33]  Hong Zhang,et al.  Autophagy in immunity , 2012, Autophagy.

[34]  T. V. van Gulik,et al.  The sterile immune response during hepatic ischemia/reperfusion. , 2012, Cytokine & growth factor reviews.

[35]  T. Kuroki,et al.  The effect of selective neutrophil elastase inhibitor on pancreatic islet yields and functions in rat with hypercytokinemia. , 2011, Annals of transplantation.

[36]  P. Socha,et al.  Oxidative stress in liver transplant recipients. , 2011, Annals of transplantation.

[37]  J. Lang,et al.  Role of nitric oxide in hepatic ischemia-reperfusion injury. , 2010, World journal of gastroenterology.

[38]  Hui-Chen Chen,et al.  Shikonin inhibits maturation of bone marrow‐derived dendritic cells and suppresses allergic airway inflammation in a murine model of asthma , 2010, British journal of pharmacology.

[39]  Bo Zhang,et al.  Shikonin protects mouse brain against cerebral ischemia/reperfusion injury through its antioxidant activity. , 2010, European journal of pharmacology.

[40]  Y. Abe,et al.  Mouse model of liver ischemia and reperfusion injury: method for studying reactive oxygen and nitrogen metabolites in vivo. , 2009, Free radical biology & medicine.

[41]  Z. Jia,et al.  Dehydroepiandrosterone protects vascular endothelial cells against apoptosis through a Galphai protein-dependent activation of phosphatidylinositol 3-kinase/Akt and regulation of antiapoptotic Bcl-2 expression. , 2007, Endocrinology.

[42]  S. Maddika,et al.  Cell survival, cell death and cell cycle pathways are interconnected: implications for cancer therapy. , 2007, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[43]  P. Polverini,et al.  p38 MAPK Mediates γ-Irradiation-induced Endothelial Cell Apoptosis, and Vascular Endothelial Growth Factor Protects Endothelial Cells through the Phosphoinositide 3-Kinase-Akt-Bcl-2 Pathway* , 2004, Journal of Biological Chemistry.

[44]  N. Selzner,et al.  Protective strategies against ischemic injury of the liver. , 2003, Gastroenterology.

[45]  R. Kitsis,et al.  Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. , 2000, Circulation.

[46]  G. Kroemer,et al.  Mitochondrial control of nuclear apoptosis , 1996, The Journal of experimental medicine.

[47]  K. Porter,et al.  CYTOPLASMIC COMPONENTS IN HEPATIC CELL LYSOSOMES , 1962, The Journal of cell biology.